By testing serum OPG and RANKL levels, Elfa et al. concluded that the sensitivity and specificity of serum OPG in detecting bone metastasis in breast cancer patients were 59% and 92%, respectively, while the corresponding values for the RANKL/OPG ratio were 73% and 72%, respectively [59]. This evidence concerns the gene TNFRSF11B and breast carcinoma.